{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:31:30Z","timestamp":1775061090708,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Parasitology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.pt.2026.02.009","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T05:16:04Z","timestamp":1772860564000},"page":"264-274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Controlled human helminth infection models: insights into type 2 immunity and therapeutic development"],"prefix":"10.1016","volume":"42","author":[{"given":"H. Richard","family":"Droghini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas B.","family":"Nutman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P'ng","family":"Loke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pt.2026.02.009_bb0005","doi-asserted-by":"crossref","first-page":"e533","DOI":"10.1016\/S1473-3099(23)00294-3","article-title":"Strategic and scientific contributions of human challenge trials for vaccine development: facts versus fantasy","volume":"23","author":"Abo","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pt.2026.02.009_bb0010","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/cid\/ciac820","article-title":"A systematic review of human challenge trials, designs, and safety","volume":"76","author":"Adams-Phipps","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.pt.2026.02.009_bb0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-085250","article-title":"An analysis of controlled human infection studies registered on ClinicalTrials.gov","volume":"15","author":"Toomey","year":"2025","journal-title":"BMJ Open"},{"key":"10.1016\/j.pt.2026.02.009_bb0020","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/ibd.20633","article-title":"Helminths and the IBD hygiene hypothesis","volume":"15","author":"Weinstock","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.pt.2026.02.009_bb0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/491183a","article-title":"The worm returns","volume":"491","author":"Weinstock","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.pt.2026.02.009_bb0030","doi-asserted-by":"crossref","first-page":"F1000","DOI":"10.12688\/f1000research.15596.1","article-title":"Helminth parasites and immune regulation","volume":"7","author":"Gazzinelli-Guimaraes","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.pt.2026.02.009_bb0035","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0034-5288(18)33478-7","article-title":"The relationship between Trichuris trichiura (Linnaeus 1758) of man and Trichuris suis (Schrank 1788) of the pig","volume":"20","author":"Beer","year":"1976","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.pt.2026.02.009_bb0040","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/gut.2004.041749","article-title":"Trichuris suis therapy in Crohn\u2019s disease","volume":"54","author":"Summers","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.pt.2026.02.009_bb0045","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1111\/j.1572-0241.2003.07660.x","article-title":"Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease","volume":"98","author":"Summers","year":"2003","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.pt.2026.02.009_bb0050","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/apt.12366","article-title":"Randomised clinical trial: the safety and tolerability of Trichuris suis ova in patients with Crohn\u2019s disease","volume":"38","author":"Sandborn","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.pt.2026.02.009_bb0055","first-page":"390","article-title":"A randomised, double-blind, placebo-controlled trial of Trichuris suis ova in active Crohn\u2019s disease","volume":"11","author":"Sch\u00f6lmerich","year":"2017","journal-title":"J. Crohns Colitis."},{"key":"10.1016\/j.pt.2026.02.009_bb0060","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/ecco-jcc\/jjae095","article-title":"Probiotic treatment of ulcerative colitis with Trichuris suis ova: a randomised, double-blinded, placebo-controlled clinical trial [the PROCTO Trial]","volume":"18","author":"Prosberg","year":"2024","journal-title":"J. Crohns Colitis."},{"key":"10.1016\/j.pt.2026.02.009_bb0065","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/1352458511398054","article-title":"Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study","volume":"17","author":"Fleming","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.pt.2026.02.009_bb0070","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/1352458517736377","article-title":"Safety and efficacy of helminth treatment in relapsing-remitting multiple sclerosis: results of the HINT 2 clinical trial","volume":"25","author":"Fleming","year":"2019","journal-title":"Mult. Scler."},{"key":"10.1016\/j.pt.2026.02.009_bb0075","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1177\/1352458514568173","article-title":"Trichuris suis ova therapy in relapsing multiple sclerosis is safe but without signals of beneficial effect","volume":"21","author":"Voldsgaard","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.pt.2026.02.009_bb0080","first-page":"101","article-title":"The worm-specific immune response in multiple sclerosis patients receiving controlled Trichuris suis ova immunotherapy","volume":"11","author":"Yordanova","year":"2021","journal-title":"Life (Basel)"},{"key":"10.1016\/j.pt.2026.02.009_bb0085","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jaci.2009.08.006","article-title":"Trichuris suis ova therapy for allergic rhinitis: a randomized, double-blind, placebo-controlled clinical trial","volume":"125","author":"Bager","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.pt.2026.02.009_bb0090","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/15622975.2018.1523561","article-title":"Randomized crossover feasibility trial of helminthic Trichuris suis ova versus placebo for repetitive behaviors in adult autism spectrum disorder","volume":"21","author":"Hollander","year":"2020","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.pt.2026.02.009_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009908","article-title":"Experimental human hookworm infection: a narrative historical review","volume":"15","author":"Chapman","year":"2021","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2026.02.009_bb0100","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1365-2222.2009.03187.x","article-title":"Safety of hookworm infection in individuals with measurable airway responsiveness: a randomized placebo-controlled feasibility study","volume":"39","author":"Feary","year":"2009","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.pt.2026.02.009_bb0105","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2222.2009.03433.x","article-title":"Experimental hookworm infection: a randomized placebo-controlled trial in asthma","volume":"40","author":"Feary","year":"2010","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.pt.2026.02.009_bb0110","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jaci.2014.07.022","article-title":"Experimental hookworm infection and gluten microchallenge promote tolerance in celiac disease","volume":"135","author":"Croese","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.pt.2026.02.009_bb0115","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000274","article-title":"Randomized, placebo controlled trial of experimental hookworm infection for improving gluten tolerance in celiac disease","volume":"11","author":"Croese","year":"2020","journal-title":"Clin. Transl. Gastroenterol."},{"key":"10.1016\/j.pt.2026.02.009_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017366","article-title":"Effect of hookworm infection on wheat challenge in celiac disease\u2014a randomised double-blinded placebo controlled trial","volume":"6","author":"Daveson","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pt.2026.02.009_bb0125","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1001\/jamaneurol.2020.1118","article-title":"Hookworm treatment for relapsing multiple sclerosis: a randomized double-blinded placebo-controlled trial","volume":"77","author":"Tanasescu","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.pt.2026.02.009_bb0130","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1038\/s41467-023-40263-4","article-title":"Effect of experimental hookworm infection on insulin resistance in people at risk of type 2 diabetes","volume":"14","author":"Pierce","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pt.2026.02.009_bb0135","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0035-9203(78)90303-6","article-title":"Antibody responses in self-infections with Necator americanus","volume":"72","author":"Ogilvie","year":"1978","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2026.02.009_bb0140","doi-asserted-by":"crossref","first-page":"387","DOI":"10.4269\/ajtmh.1984.33.387","article-title":"Larvicidal activity of albendazole against Necator americanus in human volunteers","volume":"33","author":"Cline","year":"1984","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2026.02.009_bb0145","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4269\/ajtmh.1987.37.126","article-title":"The clinical and immunologic responses of normal human volunteers to low dose hookworm (Necator americanus) infection","volume":"37","author":"Maxwell","year":"1987","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2026.02.009_bb0150","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1365-2249.2005.02945.x","article-title":"Immune responses following experimental human hookworm infection","volume":"142","author":"Wright","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.pt.2026.02.009_bb0155","doi-asserted-by":"crossref","first-page":"914","DOI":"10.4269\/ajtmh.2006.75.914","article-title":"Dose-ranging study for trials of therapeutic infection with Necator americanus in humans","volume":"75","author":"Mortimer","year":"2006","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2026.02.009_bb0160","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.micinf.2008.09.003","article-title":"Early stage-specific immune responses in primary experimental human hookworm infection","volume":"10","author":"Geiger","year":"2008","journal-title":"Microbes Infect."},{"key":"10.1016\/j.pt.2026.02.009_bb0165","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/S1473-3099(21)00153-5","article-title":"Vaccination of human participants with attenuated Necator americanus hookworm larvae and human challenge in Australia: a dose-finding study and randomised, placebo-controlled, phase 1 trial","volume":"21","author":"Chapman","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pt.2026.02.009_bb0170","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/infdis\/jiaa414","article-title":"A randomized controlled trial to investigate safety and variability of egg excretion after repeated controlled human hookworm infection","volume":"223","author":"Hoogerwerf","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2026.02.009_bb0175","doi-asserted-by":"crossref","first-page":"e1024","DOI":"10.1016\/S2666-5247(23)00218-5","article-title":"Protective efficacy of short-term infection with Necator americanus hookworm larvae in healthy volunteers in the Netherlands: a single-centre, placebo-controlled, randomised, controlled, phase 1 trial","volume":"4","author":"Hoogerwerf","year":"2023","journal-title":"Lancet Microbe."},{"key":"10.1016\/j.pt.2026.02.009_bb0180","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1084\/jem.20111381","article-title":"Schistosome-derived omega-1 drives Th2 polarization by suppressing protein synthesis following internalization by the mannose receptor","volume":"209","author":"Everts","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.pt.2026.02.009_bb0185","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41591-020-0759-x","article-title":"A controlled human Schistosoma mansoni infection model to advance novel drugs, vaccines and diagnostics","volume":"26","author":"Langenberg","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.pt.2026.02.009_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104832","article-title":"Safety and infectivity of female cercariae in Schistosoma-na\u00efve, healthy participants: a controlled human Schistosoma mansoni infection study","volume":"97","author":"Koopman","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.pt.2026.02.009_bb0195","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/491183a","article-title":"Autoimmunity: the worm returns","volume":"491","author":"Weinstock","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.pt.2026.02.009_bb0200","first-page":"106","article-title":"Non-encapsulated Trichinella spp., T. papuae, diminishes severity of DSS-induced colitis in mice","volume":"31","author":"Adisakwattana","year":"2013","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"10.1016\/j.pt.2026.02.009_bb0205","doi-asserted-by":"crossref","first-page":"G385","DOI":"10.1152\/ajpgi.00049.2002","article-title":"Exposure to schistosome eggs protects mice from TNBS-induced colitis","volume":"284","author":"Elliott","year":"2003","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.pt.2026.02.009_bb0210","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1002\/eji.200324833","article-title":"Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice","volume":"34","author":"Elliott","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.pt.2026.02.009_bb0215","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1126\/science.aaf3229","article-title":"Helminth infection promotes colonization resistance via type 2 immunity","volume":"352","author":"Ramanan","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.pt.2026.02.009_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.parint.2021.102441","article-title":"Safety and tolerability of medicinal parasite ova (Trichuris suis) in healthy Japanese volunteers: a randomized, double-blind, placebo-controlled trial","volume":"85","author":"Hoshina","year":"2021","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.pt.2026.02.009_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022346","article-title":"Symptoms after ingestion of pig whipworm Trichuris suis eggs in a randomized placebo-controlled double-blind clinical trial","volume":"6","author":"Bager","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pt.2026.02.009_bb0230","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001500","article-title":"IL-22+ CD4+ T cells are associated with therapeutic Trichuris trichiura infection in an ulcerative colitis patient","volume":"2","author":"Broadhurst","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.pt.2026.02.009_bb0235","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12394","article-title":"Mucosal and systemic immune modulation by Trichuris trichiura in a self-infected individual","volume":"39","author":"Dige","year":"2017","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.pt.2026.02.009_bb0240","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.1038\/s41467-024-50313-0","article-title":"Controlled human hookworm infection remodels plasmacytoid dendritic cells and regulatory T cells towards profiles seen in natural infections in endemic areas","volume":"15","author":"Manurung","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pt.2026.02.009_bb0245","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1001\/jamaneurol.2020.1118","article-title":"Hookworm treatment for relapsing multiple sclerosis: a randomized double-blinded placebo-controlled trial","volume":"77","author":"Tanasescu","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.pt.2026.02.009_bb0250","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.exppara.2012.11.010","article-title":"Frequency and intensity of exposure mediate resistance to experimental infection with the hookworm, Ancylostoma ceylanicum","volume":"133","author":"Davey","year":"2013","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.pt.2026.02.009_bb0255","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/pim.12088","article-title":"Immunology of experimental and natural human hookworm infection","volume":"36","author":"Gaze","year":"2014","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.pt.2026.02.009_bb0260","doi-asserted-by":"crossref","first-page":"911","DOI":"10.4269\/ajtmh.2009.09-0237","article-title":"Immunologic profiles of persons recruited for a randomized, placebo-controlled clinical trial of hookworm infection","volume":"81","author":"Blount","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2026.02.009_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002520","article-title":"Characterising the mucosal and systemic immune responses to experimental human hookworm infection","volume":"8","author":"Gaze","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.pt.2026.02.009_bb0270","article-title":"Clinical tolerance but no protective efficacy in a placebo-controlled trial of repeated controlled schistosome infection","volume":"135","author":"Koopman","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pt.2026.02.009_bb0275","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adl1965","article-title":"Early symptom-associated inflammatory responses shift to type 2 responses in controlled human schistosome infection","volume":"9","author":"Houlder","year":"2024","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.pt.2026.02.009_bb0280","doi-asserted-by":"crossref","first-page":"6827","DOI":"10.1038\/s41467-025-62144-8","article-title":"T cell responses in repeated controlled human schistosome infection compared to natural exposure","volume":"16","author":"Driciru","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pt.2026.02.009_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2021.108189","article-title":"Potential of human helminth therapy for resolution of inflammatory bowel disease: the future ahead","volume":"232","author":"Arai","year":"2022","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.pt.2026.02.009_bb0290","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jaci.2012.04.027","article-title":"Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: implications for the development of vaccines against helminths","volume":"130","author":"Diemert","year":"2012","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Trends in Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492226000450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492226000450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T14:58:47Z","timestamp":1775055527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471492226000450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1471492226000450"],"URL":"https:\/\/doi.org\/10.1016\/j.pt.2026.02.009","relation":{},"ISSN":["1471-4922"],"issn-type":[{"value":"1471-4922","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Controlled human helminth infection models: insights into type 2 immunity and therapeutic development","name":"articletitle","label":"Article Title"},{"value":"Trends in Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pt.2026.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}